U.S. markets closed

BioLineRx Ltd. (BLRX.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA
Add to watchlist
60.20+1.40 (+2.38%)
At close: 2:24PM IDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close58.80
Open59.80
Bid58.80 x 255900
Ask59.00 x 42900
Day's Range59.80 - 60.70
52 Week Range32.70 - 136.00
Volume364,688
Avg. Volume1,328,178
Market Cap42.689B
Beta (5Y Monthly)1.48
PE Ratio (TTM)N/A
EPS (TTM)-0.07
Earnings DateAug 06, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update

      BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended June 30, 2021 and provides a corporate update.

    • PR Newswire

      BioLineRx to Report Second Quarter 2021 Results on August 18, 2021

      BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for the quarter ended June 30, 2021 on Wednesday, August 18, 2021, before the US markets open.

    • Insider Monkey

      Is Bioline RX Ltd (BLRX) A Good Stock To Buy?

      The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]